{
    "paper_id": "6f1a9966956dbf1fe2d075040594d3a1f8c28911",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Diese Empfehlung ist unumstrit ten, jedoch im Einzelfall schwer in die Realit\u00e4t umzusetzen. Denn f\u00fcr die meisten f\u00fcr die Intensiv medizin bedeutsamen Virusin fektionen (vielleicht mit Ausnah me einer CMVInfektion) gibt es keine etablierte wirksame anti virale Therapie, auch bei Influen Originalpublikationen Gao ",
            "cite_spans": [
                {
                    "start": 309,
                    "end": 312,
                    "text": "Gao",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Fr\u00fcher Beginn der antiviralen Therapie, wenn V.a. viraler Fokus bei Sepsis und septischer Schock"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "Perez",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Immunol",
            "volume": "186",
            "issn": "",
            "pages": "987--993",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak",
            "authors": [
                {
                    "first": "Z",
                    "middle": [
                        "M"
                    ],
                    "last": "Sheng",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "S"
                    ],
                    "last": "Chertow",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ambroggio",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "108",
            "issn": "",
            "pages": "16416--16421",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Baum",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Schweiger",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Welte",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "The burden of pneumococcal pneumonia -experience of the German competence network CAPNETZ",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Pletz",
                    "suffix": ""
                },
                {
                    "first": "Von",
                    "middle": [],
                    "last": "Baum",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Van Der Linden",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Pneumologie",
            "volume": "66",
            "issn": "",
            "pages": "470--475",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Middle East respiratory syndrome coronavirus infections in health care workers",
            "authors": [
                {
                    "first": "Z",
                    "middle": [
                        "A"
                    ],
                    "last": "Memish",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "I"
                    ],
                    "last": "Zumla",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Assiri",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "N Engl J Med",
            "volume": "369",
            "issn": "",
            "pages": "884--886",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Vaccines against influenza WHO position paper",
            "authors": [],
            "year": 2012,
            "venue": "Wkly Epidemiol Rec",
            "volume": "87",
            "issn": "",
            "pages": "461--476",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Symptomatik, meist am zwei ten oder dritten Tag der Erkran kung. Die einzige m\u00f6glicherweise den Krankheitsverlauf beeinflus sende Therapie, der Einsatz von Neuraminidasehemmern, wirkt jedoch nur, wenn die Therapie innerhalb der ersten 36 Stunden nach Krankheitsbeginn startet. In der Regel wird mit der The rapie zu sp\u00e4t begonnen, was die geringen Effekte dieser Substan zen in verschiedenen Metaana lysen erkl\u00e4rt [2,3]. Zudem ist die Inkubationszeit von Influenza kurz (1-2 Tage), Isolationsma\u00df nahmen, die 2003 bei der durch Coronavirus ausgel\u00f6sten SARS Epidemie zur Eind\u00e4mmung der Erkrankung beitrugen, sind bei Influenza wenig erfolgreich. Literatur Originalpublikation Muscedere J, Ofner M, Kumar A et al (2013) The Occurrence and Impact of Bacterial Organisms. Complicating Critical Care Illness Associated With 2009 Influenza A(H1N1) Infection. Chest 144:39-47 Prokocimer P, De Anda C, Fang E et al (2013) Tedizolid phosphate vs. linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. JAMA 309:559-569 Tab. 1 Impfempfehlungen der WHO f\u00fcr die Influenzaimpfung (modifiziert nach [6]) Kinder im Alter von 6 bis 23 Monaten Kinder im Alter von 2 bis 5 Jahren \u00c4ltere Menschen im Alter von > 65 Jahren",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}